Streamline Health Solutions, Inc.
STRM · NASDAQ
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.10 | -0.87 | 0.67 |
| FCF Yield | -12.86% | -3.37% | -1.44% | -1.25% |
| EV / EBITDA | -8.92 | -9.45 | -101.40 | -136.69 |
| Quality | ||||
| ROIC | -31.31% | -66.32% | -23.94% | -22.43% |
| Gross Margin | 46.58% | 51.08% | 46.18% | 50.65% |
| Cash Conversion Ratio | 0.15 | 0.12 | 0.63 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.40% | 9.14% | 29.93% | -5.73% |
| Free Cash Flow Growth | 38.16% | 57.74% | -81.45% | 34.04% |
| Safety | ||||
| Net Debt / EBITDA | -3.32 | -0.58 | -0.50 | -0.09 |
| Interest Coverage | -3.99 | -18.34 | -14.46 | -45.62 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 5.53 | 39.66 | 110.22 | 64.89 |